Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 20/20 | 0.44 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.42 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4233505 | 0.89 | SCN9A (0.52) | SCN9ASCN10ASCN7AKCNH2SCN5A | |
| SCHEMBL4233483 | 0.85 | SCN9A (0.47) | SCN9ASCN10ASCN7AKCNH2SCN5A | |
| SCHEMBL4916822 | 0.84 | PPARG (0.47) | SCN9A | |
| SCHEMBL333599 | 0.77 | LMNA (0.50) | SCN9A | |
| SCHEMBL4227684 | 0.77 | PPARG (0.43) | SCN9A | |
| SCHEMBL5266287 | 0.77 | SCN9A (0.45) | SCN9ASCN10ASCN7AKCNH2SCN5A | |
| SCHEMBL333775 | 0.77 | PPARG (0.48) | SCN9A | |
| SCHEMBL4228442 | 0.77 | EGLN1 (0.43) | SCN9A | |
| SCHEMBL333600 | 0.76 | LMNA (0.48) | SCN9A | |
| SCHEMBL4226245 | 0.76 | PPARG (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090042949-A1 | Indoles Useful in the Treatment of Inflammation | BIOLIPOX AB (SE) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042949-A1 | Indoles Useful in the Treatment of Inflammation | IDO1, IDO2, AREG | SCN9A 4230/4885SCN10A 3815/4885SCN7A 4340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.